Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Air Liquide SA |
---|---|
Information provided by: | Air Liquide SA |
ClinicalTrials.gov Identifier: | NCT00800072 |
The purpose of this study is to evaluate the duration of oxygen use recorded by the NOWOX, under usual conditions of daily living, in patients with chronic obstructive respiratory disease requiring oxygen therapy.
Condition | Intervention |
---|---|
Chronic Obstructive Pulmonary Disease |
Device: NOWOX |
Study Type: | Interventional |
Study Design: | Open Label, Uncontrolled, Single Group Assignment |
Official Title: | Evaluation of NOWOX: a Medical Device Developed to Record Duration of Oxygen Use and Respiration Rate in Patients Requiring Oxygen Therapy |
Estimated Enrollment: | 1 |
Study Start Date: | November 2008 |
Estimated Study Completion Date: | February 2009 |
Estimated Primary Completion Date: | January 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
oxygen therapy: Experimental
one experimental device assigned to each of the 10 patients including in the study for an experiemental session duration of 6 hours
|
Device: NOWOX
one experimental device assigned to each of the 10 patients including in the study for an experiemental session duration of 6 hours
|
Long Term Oxygen Therapy (LTOT) is one of the main non pharmacologic treatments for patients with severe lung disease. This continuous or sub-continuous oxygen supplementation is generally introduced at home in patients who have chronic cardio respiratory failure and severe resting hypoxemia to maintain sufficient blood oxygenation and therefore preserve vital organ function.
LTOT effectiveness has mainly been evaluated and documented in patients with COPD, which also accounts for most of its prescriptions. In these patients, LTOT has been shown to have a beneficial impact on haemodynamics, exercise capacity, lung mechanics and mental state. Its implementation was furthermore associated with reduced yearly hospitalisation days and increased survival Measuring adherence is an extremely important and under-evaluated component of oxygen therapy. NOWOX, medical device has been designed,developed and manufactured to measure adherence to LTOT and additionally to measure patient's respiration rate
Ages Eligible for Study: | 18 Years to 75 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Anh-Tuan DINH-XUAN, Professor-MD | + 33 1 58 41 22 91 | anh-tuan.dinh-xuan@cch.aphp.fr |
France | |
Cochin University Hospital | Recruiting |
PARIS, France, 75014 | |
Principal Investigator: Anh-Tuan DINH-XUAN, MD Professor |
Principal Investigator: | Anh-Tuan DINH-XUAN, Professor-MD | Department of Physiology - Cochin University Hospital - FRANCE |
Responsible Party: | AIR LIQUIDE SA ( Mr Philippe ROUAULT/Director CRCD ) |
Study ID Numbers: | ALMED-07-MD-015 |
Study First Received: | November 28, 2008 |
Last Updated: | November 28, 2008 |
ClinicalTrials.gov Identifier: | NCT00800072 |
Health Authority: | France: Afssaps - French Health Products Safety Agency |
to verify accurrancy of data collected by the NOWOX |
Lung Diseases, Obstructive Respiratory Tract Diseases Lung Diseases Pulmonary Disease, Chronic Obstructive |